Published guidance, NICE advice and quality standards | Guidance

Showing 711 to 720 of 901

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Nivolumab for treating advanced (unresectable or metastatic) melanoma	TA384	18 February 2016	18 February 2016
TNF-alpha inhibitors for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	1 February 2016	1 February 2016
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated	TA377	27 January 2016	27 January 2016
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy	TA378	27 January 2016	27 January 2016
Nintedanib for treating idiopathic pulmonary fibrosis	TA379	27 January 2016	27 January 2016
Panobinostat for treating multiple myeloma after at least 2 previous treatments	TA380	27 January 2016	27 January 2016
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)	TA382	27 January 2016	27 January 2016
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	26 January 2016	26 January 2016
Guidance on the use of imatinib for chronic myeloid leukaemia	TA70	22 October 2003	21 January 2016
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015